HUBUNGAN STRUKTUR MOLEKUL OBAT DENGAN AFINITAS TERHADAP RESEPTOR: TINJAUAN STRUKTUR–AKTIVITAS DALAM KIMIA MEDISINAL

  • Nerdy Nerdy Universitas Tjut Nyak Dhien, Medan
  • Rahma Yulia Universitas Tjut Nyak Dhien, Medan
  • Anggi Ersa Nabila Sitorus Universitas Tjut Nyak Dhien, Medan
  • Septia Siska Horoni Universitas Tjut Nyak Dhien, Medan
  • Zesica Khairunisa Universitas Tjut Nyak Dhien, Medan
  • Iffana Isman Universitas Tjut Nyak Dhien, Medan
  • Nellia Putri Universitas Tjut Nyak Dhien, Medan
  • Nadia Putri Neza Universitas Tjut Nyak Dhien, Medan
  • Nurul Syaukia Rahayu Lubis Universitas Tjut Nyak Dhien, Medan
  • Frisca Febrilia Tumangger Universitas Tjut Nyak Dhien, Medan
  • Atsillah Zayan Faidah S Universitas Tjut Nyak Dhien, Medan
  • Noni Kristin Hulu Universitas Tjut Nyak Dhien, Medan
  • Najwa Putri Iskandar Universitas Tjut Nyak Dhien, Medan
  • Agnes Cindi Rosalia Larosa Universitas Tjut Nyak Dhien, Medan
  • Dhyarticha Geralda Sibarani Universitas Tjut Nyak Dhien, Medan
  • Sri Kumala Dewi Universitas Tjut Nyak Dhien, Medan
Keywords: Medicinal Chemistry, Structure–Activity Relationship, Molecular Structure, Receptor Affinity, Molecular Recognition

Abstract

This narrative review examined how molecular structure determined drug affinity toward biological receptors within the framework of medicinal chemistry structure–activity relationships. The review integrated recent evidence on intermolecular forces, physicochemical properties, conformational organization, stereochemistry, solvation, bioisosteric replacement, fluorination, and computational approaches used to interpret ligand–receptor recognition. The findings showed that affinity was not governed by a single functional group or descriptor, but by the cooperative balance of geometric complementarity, electrostatics, hydrogen and halogen bonding, hydrophobic contacts, cation–π interactions, desolvation, and conformational entropy. Small structural modifications could therefore produce either gradual potency changes or pronounced activity cliffs when they altered binding pose, protonation, hydration networks, or receptor dynamics. Structure–activity analysis was most informative when equilibrium affinity was interpreted together with thermodynamic and kinetic parameters and verified by structural or computational evidence. Rational optimization consequently required maintaining target complementarity while controlling lipophilicity, flexibility, polarity, and developability properties.

References

Persch, E., Dumele, O., & Diederich, F. (2015). Molecular recognition in chemical and biological systems. Angewandte Chemie International Edition, 54(11), 3290–3327. https://doi.org/10.1002/anie.201408487
Caron, G., Kihlberg, J., & Ermondi, G. (2019). Intramolecular hydrogen bonding: An opportunity for improved design in medicinal chemistry. Medicinal Research Reviews, 39(5), 1707–1729. https://doi.org/10.1002/med.21562
Pinheiro, P. S. M., Rodrigues, D. A., Maia, R. C., Thota, S., & Fraga, C. A. M. (2019). The use of conformational restriction in medicinal chemistry. Current Topics in Medicinal Chemistry, 19(19), 1712–1733. https://doi.org/10.2174/1568026619666190712205025
Ferenczy, G. G., & Keserű, G. M. (2020). Thermodynamic profiling for fragment-based lead discovery and optimization. Expert Opinion on Drug Discovery, 15(1), 117–129. https://doi.org/10.1080/17460441.2020.1691166
Decherchi, S., & Cavalli, A. (2020). Thermodynamics and kinetics of drug-target binding by molecular simulation. Chemical Reviews, 120(23), 12788–12833. https://doi.org/10.1021/acs.chemrev.0c00534
Margiotta, E., van der Lubbe, S. C. C., Santos, L. A., Paragi, G., Moro, S., Bickelhaupt, F. M., & Fonseca Guerra, C. (2020). Halogen bonds in ligand-protein systems: Molecular orbital theory for drug design. Journal of Chemical Information and Modeling, 60(3), 1317–1328. https://doi.org/10.1021/acs.jcim.9b00946
Cramer, D. L., Cheng, B., Tian, J., Clements, J. H., Wypych, R. M., & Martin, S. F. (2020). Some thermodynamic effects of varying nonpolar surfaces in protein-ligand interactions. European Journal of Medicinal Chemistry, 208, 112771. https://doi.org/10.1016/j.ejmech.2020.112771
Achary, P. G. R. (2020). Applications of quantitative structure-activity relationships (QSAR) based virtual screening in drug design: A review. Mini-Reviews in Medicinal Chemistry, 20(14), 1375–1388. https://doi.org/10.2174/1389557520666200429102334
D’Souza, S., Prema, K. V., & Balaji, S. (2020). Machine learning models for drug-target interactions: Current knowledge and future directions. Drug Discovery Today, 25(4), 748–756. https://doi.org/10.1016/j.drudis.2020.03.003
Kim, M., Truss, M., Pagare, P. P., Essandoh, M. A., Zhang, Y., & Williams, D. A. (2020). Structure activity relationship exploration of 5-hydroxy-2-(3-phenylpropyl)chromones as a unique 5-HT2B receptor antagonist scaffold. Bioorganic & Medicinal Chemistry Letters, 30(21), 127511. https://doi.org/10.1016/j.bmcl.2020.127511
Kumari, S., Carmona, A. V., Tiwari, A. K., & Trippier, P. C. (2020). Amide bond bioisosteres: Strategies, synthesis, and successes. Journal of Medicinal Chemistry, 63(21), 12290–12358. https://doi.org/10.1021/acs.jmedchem.0c00530
Infield, D. T., Rasouli, A., Galles, G. D., Chipot, C., Tajkhorshid, E., & Ahern, C. A. (2021). Cation-π interactions and their functional roles in membrane proteins. Journal of Molecular Biology, 433(17), 167035. https://doi.org/10.1016/j.jmb.2021.167035
Hüfner-Wulsdorf, T., & Klebe, G. (2021). Mapping water thermodynamics on drug candidates via molecular building blocks: A strategy to improve ligand design and rationalize SAR. Journal of Medicinal Chemistry, 64(8), 4662–4676. https://doi.org/10.1021/acs.jmedchem.0c02115
Subbaiah, M. A. M., & Meanwell, N. A. (2021). Bioisosteres of the phenyl ring: Recent strategic applications in lead optimization and drug design. Journal of Medicinal Chemistry, 64(19), 14046–14128. https://doi.org/10.1021/acs.jmedchem.1c01215
Richardson, P. (2021). Applications of fluorine to the construction of bioisosteric elements for the purposes of novel drug discovery. Expert Opinion on Drug Discovery, 16(11), 1261–1286. https://doi.org/10.1080/17460441.2021.1933427
Pietruś, W., Kurczab, R., Stumpfe, D., Bojarski, A. J., & Bajorath, J. (2021). Data-driven analysis of fluorination of ligands of aminergic G protein coupled receptors. Biomolecules, 11(11), 1647. https://doi.org/10.3390/biom11111647
Jayashree, B. S., Nikhil, P. S., & Paul, S. (2022). Bioisosterism in drug discovery and development—An overview. Medicinal Chemistry, 18(9), 915–925. https://doi.org/10.2174/1573406418666220127124228
Sobhia, M. E., Ghosh, K., Kumar, G. S., Sivangula, S., Laddha, K., Kumari, S., & Kumar, H. (2022). The role of water network chemistry in proteins: A structural bioinformatics perspective in drug discovery and development. Current Topics in Medicinal Chemistry, 22(20), 1636–1653. https://doi.org/10.2174/1568026622666220726114407
Callis, T. B., Garrett, T. R., Montgomery, A. P., Danon, J. J., & Kassiou, M. (2022). Recent scaffold hopping applications in central nervous system drug discovery. Journal of Medicinal Chemistry, 65(20), 13483–13504. https://doi.org/10.1021/acs.jmedchem.2c00969
Qin, Y., Poulsen, C., Narayanan, D., Chan, C. B., Chen, X., Montes, B. R., ... Bach, A. (2024). Structure-guided conformational restriction leading to high-affinity, selective, and cell-active tetrahydroisoquinoline-based noncovalent Keap1-Nrf2 inhibitors. Journal of Medicinal Chemistry, 67(21), 18828–18864. https://doi.org/10.1021/acs.jmedchem.4c01221
Dougherty, D. A. (2025). The cation-π interaction in chemistry and biology. Chemical Reviews, 125(5), 2793–2808. https://doi.org/10.1021/acs.chemrev.4c00707
Published
2026-09-01
How to Cite
Nerdy Nerdy, Rahma Yulia, Anggi Ersa Nabila Sitorus, Septia Siska Horoni, Zesica Khairunisa, Iffana Isman, Nellia Putri, Nadia Putri Neza, Nurul Syaukia Rahayu Lubis, Frisca Febrilia Tumangger, Atsillah Zayan Faidah S, Noni Kristin Hulu, Najwa Putri Iskandar, Agnes Cindi Rosalia Larosa, Dhyarticha Geralda Sibarani, & Sri Kumala Dewi. (2026). HUBUNGAN STRUKTUR MOLEKUL OBAT DENGAN AFINITAS TERHADAP RESEPTOR: TINJAUAN STRUKTUR–AKTIVITAS DALAM KIMIA MEDISINAL. EDU RESEARCH, 7(2), 9064-9078. https://doi.org/10.47827/jer.v7i2.3634
Section
Articles